Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels?
about
Dosing of antibacterial agents in obese adults: does one size fit all?Update on best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery, 2004-2007.Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens.Standard perioperative management in gastrointestinal surgeryAntibiotic prophylaxis in obese patients submitted to bariatric surgery. A systematic review.Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin.Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy.Case-control study of drug monitoring of β-lactams in obese critically ill patients.Preventing deep wound infection after coronary artery bypass grafting: a reviewPharmacokinetic and Pharmacodynamic Evaluation of a Weight-Based Dosing Regimen of Cefoxitin for Perioperative Surgical Prophylaxis in Obese and Morbidly Obese PatientsBody mass index and risk of surgical site infection following spine surgery: a meta-analysis.Obesity and the orthopedic trauma patient: a review of the risks and challenges in medical and surgical management.Appendicitis in obese children.Interaction of obesity and infections.Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients.Evaluation of cephalexin failure rates in morbidly obese patients with cellulitis.ANTIBIOTIC PROPHYLAXIS IN BARIATRIC SURGERY: a continuous infusion of cefazolin versus ampicillin/sulbactam and ertapenem.Patient care interventions to help reduce the risk of surgical site infections.Neutrophil killing of Staphylococcus aureus in diabetes, obesity and metabolic syndrome: a prospective cellular surveillance study.Guideline for Antimicrobial Prophylaxis in Breast Surgery.Skeletal muscle and plasma concentrations of cefazolin.Serum in vivo and in vitro activity of single dose of ertapenem in surgical obese patients for prevention of SSIs.Cefepime dosing in the morbidly obese patient population.Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.Perioperative Antibiotics
P2860
Q30362353-CBD809C6-4739-4EB5-A38E-202F91D403CBQ33435250-77532631-D252-4AF3-9CD0-FE56DCEE25C3Q33995500-75D0F1DF-2211-4EFB-AAE8-B9A15E5D0D24Q35004732-CB804AB5-0AC9-4DD4-8E5B-0708AAC38B53Q35120312-56FD1A0A-32AF-4521-9210-066B6D7D3438Q35912780-4FCB1C2F-1EE1-454E-9901-6F861CA42666Q36471339-E9AED69F-1FF7-4A87-ADB8-E7068735AF7FQ36558332-6DEA6406-B87B-4515-BFBE-2FB24ECA78E9Q36831165-A5893EEA-2415-43C8-9574-00DB5EC20778Q37287895-21AF06A2-CC0B-4549-875B-A22DAC122D76Q37350597-81B6B8B3-366D-4F95-B5DA-1DB803D47022Q37858378-2FD8D970-5B88-427F-A95C-8E9908DE9CA9Q38087908-CDB92FD6-97A4-45EF-BB81-3CE1C0498E38Q38583848-33A6FF73-7F6D-45CD-9631-9433FA70F325Q39025685-52FDF6FA-D078-454D-9179-1883D62EC1BEQ39755697-6AF9982B-BE4C-4E62-A161-CF2601D05494Q41187601-87D23D6B-6A11-448F-BA13-F73664E39216Q41631232-4BD8C0AF-4CB3-4D8A-8447-71FA79074724Q42281025-AEA4ED2C-C7A6-4DC5-BF06-1AEA7C5142A6Q42316310-19201F80-0C8F-4878-B57E-143E1A8EA207Q42619023-C6B1E070-541D-4A33-8CFF-67495C8EF808Q44165112-B4CB19EF-B821-4521-9F0F-F42CCAF21171Q44189639-C4AE4D2B-CF43-4E6E-99BC-AEA7F995AFFBQ45236532-F37118D0-683F-4171-918F-A7375F48D7EBQ54626808-DF389441-2D9E-4E79-9FA2-3D2CEFB46A97Q56928143-D2D71465-28FD-44B5-9808-11136D9E6374
P2860
Perioperative antibiotic prophylaxis in the gastric bypass patient: do we achieve therapeutic levels?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Perioperative antibiotic proph ...... we achieve therapeutic levels?
@en
Perioperative antibiotic proph ...... we achieve therapeutic levels?
@nl
type
label
Perioperative antibiotic proph ...... we achieve therapeutic levels?
@en
Perioperative antibiotic proph ...... we achieve therapeutic levels?
@nl
prefLabel
Perioperative antibiotic proph ...... we achieve therapeutic levels?
@en
Perioperative antibiotic proph ...... we achieve therapeutic levels?
@nl
P2093
P1433
P1476
Perioperative antibiotic proph ...... we achieve therapeutic levels?
@en
P2093
Atilla Nakeeb
Candace Krepel
Charles E Edmiston
Cindy Hennen
Deborah Andris
Holly Kelly
James R Wallace
Jeffery Larson
P304
P356
10.1016/J.SURG.2004.06.022
P407
P577
2004-10-01T00:00:00Z